Bookmark and Share
Adenosine Monophosphate (CID 6083) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(46)
 
 
Inactive(185)
 
 
Inconclusive(26)
 
 
Unspecified(57)
 
 
Top Targets:
NR LBD PPAR(8)
 
 
 
NR LBD ER(7)
 
 
NR LBD AR(7)
 
 
 
FBPase(6)
 
 
NR LBD VDR(5)
 
 
 
BioAssay Types:
Literature(167)
 
 
 
 
 
Confirmatory(117)
 
 
 
 
Summary(24)
 
 
 
Screening(2)
 
 
BioActivity Types:
Potency(130)
 
 
 
 
IC50(15)
 
 
 
 
 
Kd(9)
 
 
 
 
Ki(8)
 
 
 
EC50(7)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 244    Data Row: 314   Total Pages: 7   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103201463]
Ki 0.00023Inhibition constant against HIV-1 Protease [AID160455, Type: Literature]Pol polyprotein [gi:75593047]
View
2
[SID103201463]
Kd 0.00113Equilibrium constant for the interaction between inhibitor and HIV-1 Protease [AID162706, Type: Literature]Pol polyprotein [gi:75593047]
View
3
[SID103201463]
IC50 0.1Inhibition of p60c-src expressed in chick embryo fibroblast [AID358183, Type: Literature]
View
4
[SID103201463]
IC50 0.14Inhibition of FBPase in human liver using fructose-2,6phosphate as a substrate [AID453457, Type: Literature]Fructose-1,6-bisphosphatase 1 [gi:311033495]
View
5
[SID103201463]
IC50 0.3Inhibition of Rous sarcoma virus p60 v-src-induced IgG phosphorylation in tumor bearing rabbits by SDS PAGE [AID358182, Type: Literature]
View
6
[SID103201463]
IC50 0.44Inhibition of FBPase in human liver [AID453456, Type: Literature]Fructose-1,6-bisphosphatase 1 [gi:311033495]
View
7
[SID103201463]
EC50 0.5Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay [AID699044, Type: Literature]Adenosine receptor A1 [gi:231473]
View
8
[SID103201463]
IC50 0.8Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase. [AID89523, Type: Literature]
View
9
[SID103201463]
IC50 1Inhibition of rat FBPase [AID580981, Type: other]
View
10
[SID103201463]
IC50 1Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry [AID354019, Type: Literature]Fructose-1,6-bisphosphatase 1 [gi:311033495]
View
11
[SID103201463]
IC50 1.3Inhibition of pig FBPase expressed in Escherichia coli EK1601 by spectrophotometry [AID419859, Type: Literature]Fructose-1,6-bisphosphatase 1 [gi:1706735]
View
12
[SID103201463]
IC50 1.3Inhibition of pig kidney fructose-1,6-bisphosphatase expressed in Escherichia coli BL21 (DE3) assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase/glucose-6-phosphate dehydrogenase coupled assay [AID477766, Type: Literature]Fructose-1,6-bisphosphatase 1 [gi:1706735]
View
13
[SID103201463]
EC50 1.4Activation of rat GPPase [AID580980, Type: other]
View
14
[SID103201463]
Kd 2.7Dissociation constant of the compound [AID238114, Type: Literature]
View
15
[SID103201463]
EC50 3.5Measure of Agonist Potency at turkey Purinoceptor P2Y1 stably expressed in 131N1 astrocytoma cell [AID165253, Type: Literature]P2Y purinoceptor 1 [gi:1352693]
View
16
[SID103201463]
EC50 3.7Measure of Agonist Potency at human P2Y purinoceptor 2 (hP2Y2) stably expressed in 131N1 astrocytoma cell [AID150498, Type: Literature]
View
17
[SID103201463]
Kd 5.4Displacement of [35S]APS from Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase by liquid scintillation counting [AID440580, Type: Literature]
View
18
[SID103201463]
Kd 5.4Binding affinity to Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase assessed as S-sulfocysteine formation at pH 7.5 by single turnover method in absence of MgCl2 [AID440581, Type: Literature]
View
19
[SID103201463]
EC50 5.9Activation of human AMPK after 15 mins [AID580978, Type: other]
View
20
[SID103201463]
EC50 7.2Measure of Agonist Potency at human P2Y purinoceptor 1 (hP2Y1) stably expressed in 131N1 astrocytoma cell [AID150332, Type: Literature]
View
21
[SID103201463]
IC50 9.8Inhibition of human liver fructose-1,6-bisphosphatase expressed in Escherichia coli BL21 (DE3) assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase/glucose-6-phosphate dehydrogenase coupled assay [AID477767, Type: Literature]Fructose-1,6-bisphosphatase 1 [gi:311033495]
View
22
[SID170466132]
Potency-Replicate_1 10.5901qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen [AID743224, Type: confirmatory]
View
23
[SID170466132]
Potency-Replicate_1 10.5901qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen [AID743211, Type: confirmatory]
View
24
[SID170466132]
Potency-Replicate_1 10.6822qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen [AID743225, Type: confirmatory]
View
25
[SID170466132]
Potency-Replicate_1 11.8823qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen [AID743213, Type: confirmatory]
View
26
[SID103201463]
IC50 12.3Inhibition of human recombinant FBPase using fructose-1,6-biphosphate as substrate incubated for 3 mins prior to substrate addition by spectrophotometric analysis [AID684832, Type: Literature]
View
27
[SID170466132]
Potency-Replicate_1 13.3322qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen [AID743221, Type: confirmatory]
View
28
[SID103201463]
Km 14Activity at ecto-5'-nucleotidase [AID448478, Type: Literature]
View
29
[SID103201463]
EC50 17.25Measure of Agonist Potency at human P2Y purinoceptor 11 (hP2Y11) stably expressed in 131N1 astrocytoma cell at 10 uM [AID150488, Type: Literature]
View
30
[SID103201463]
Kd 21Binding affinity to Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase assessed as S-sulfocysteine formation at pH 7.5 by single turnover method in presence of 0.5 mM MgCl2 [AID440582, Type: Literature]
View
31
[SID144205599]
Potency-Replicate_1 21.3138qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen [AID743074, Type: confirmatory]
View
32
[SID103201463]
Kd 31Binding affinity to Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase assessed as S-sulfocysteine formation at pH 7.5 by single turnover method in presence of 2 mM MgCl2 [AID440583, Type: Literature]
View
33
[SID103201463]
Km 32.8Activity of recombinant human ADAL1 expressed in Escherichia coli by UV-spectrophotometry [AID612651, Type: Literature]Adenosine deaminase-like protein [gi:146286026]
View
34
[SID103201463]
Ki 38Inhibition constant was evaluated against horse liver alcohol dehydrogenase [AID33710, Type: Literature]Alcohol dehydrogenase E chain [gi:113397]
View
35
[SID103201463]
Ki 38Inhibition constant was evaluated against horse liver alcohol dehydrogenase [AID33710, Type: Literature]Alcohol dehydrogenase S chain [gi:113406]
View
36
[SID46394436]
Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature]Chain A, Structural Mechanism For Glycogen Phosphorylase Control By Phosphorylation And Amp [gi:231257]
View
37
[SID46392931]
Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature]Chain A, Structural Basis For The Activation Of Glycogen Phosphorylase B By Adenosine Monophosphate [gi:494494]
View
38
[SID46393301]
Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature]Chain A, Crystal Structure Of An Adp-Dependent Glucokinase From Pyrococcus Furiosus [gi:46015797]
View
39
[SID46393711]
Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature]Chain A, Ribonuclease A- Amp Complex [gi:75765679]
View
40
[SID46394204]
Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature]Chain A, Structure Of Xac Nucleotide Pyrophosphatase/phosphodiesterase In Complex With Amp [gi:112490889]
View
41
[SID46394446]
Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature]Chain A, Structural Mechanism For Glycogen Phosphorylase Control By Phosphorylation And Amp [gi:157837173]
View
42
[SID103201463]
Inhibition of Escherichia coli KPR at 1 mM [AID269131, Type: Literature]
View
43
[SID103201463]
Ki Binding affinity to Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase assessed as S-sulfocysteine formation at pH 5.5 by single turnover method in absence of thioredoxin [AID440574, Type: Literature]
View
44
[SID103201463]
Measure of Agonist Potency at human P2Y purinoceptor 4 (hP2Y4) stably expressed in 131N1 astrocytoma cell; Antagonist effect [AID150626, Type: Literature]
View
45
[SID103201463]
Tested for relaxation of carbachol-contracted guinea pig taenia coli at 37 degree C; Significantly less potent than ATP [AID77361, Type: Literature]
View
46
[SID48415520]
DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
47
[SID103201463]
Km 80Concentration for half-maximal velocity to Adenylate kinase III [AID35081, Type: Literature]
View
48
[SID103201463]
Km 80Concentration of compound for half-maximal velocity to Adenylate kinase II [AID34915, Type: Literature]
View
49
[SID103201463]
Ki 80Inhibitory activity against rat adenylate kinase II was determined in the presence of AMP [AID34928, Type: Literature]
View
50
[SID103201463]
Km 90Concentration for for half-maximal velocity for adenylate kinase (AK III) was determined [AID35067, Type: Literature]
View